title: Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression?
abstract: Among patients infected with human immunodeficiency virus (HIV), those with HIV-1 RNA <200 copies/mL and CD4 counts ≥300 cells/µL had a 97.1% probability of maintaining durable CD4 ≥200 cells/µL for 4 years. When non-HIV causes of CD4 lymphopenia were excluded, the probability rose to 99.2%. Our data support less frequent CD4 monitoring during viral suppression.
authors: Infectious Diseases Section, Medical Service, Veterans Affairs Medical Center, 50 Irving St NW, Washington, DC 20422, USA. howard.gale@va.gov
authors: Howard B
authors: HB
authors: Gale
authors: Steven R
authors: SR
authors: Gitterman
authors: Heather J
authors: HJ
authors: Hoffman
authors: Fred M
authors: FM
authors: Gordin
authors: Debra A
authors: DA
authors: Benator
authors: Ann M
authors: AM
authors: Labriola
authors: Virginia L
authors: VL
authors: Kan
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D016903:Drug Monitoring / Q000379:methods*; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D019562:Viral Load